Personalized Medical Care & Dedicated International Patient Concierge
Medical Guide
Sculptra vs Radiesse: Comparing Two Biostimulatory Fillers
Sculptra vs Radiesse at Liyan Clinic in Jeju: what each does on the day, what each builds over months, and the two questions that settle the choice.
Schedule a ConsultationSculptra vs Radiesse: Comparing Two Biostimulatory Fillers
Medically reviewed by Dr. Oh Eunhui, Medical Director, Liyan Clinic
Sculptra vs Radiesse is a comparison between two products that share a mechanism and disagree about almost everything else. Both prompt your body to make collagen. Only one of them also changes your face on the day you have it. That single asymmetry decides most of these cases, and it decides them faster than a list of specifications ever will.
Both are on Liyan Clinic's short list of the treatments American patients ask about, and both are injected in a single appointment of well under an hour. From there they diverge.
Same biology, opposite tempo
Take the mechanism first, because it is the part the two genuinely share.
Sculptra is poly-L-lactic acid — PLLA — dosed per vial. Its microparticles are placed deep, in the dermis and the layer of fat below it. There they are taken up and cleared over time, and as they go your own collagen is laid down in their place. The result therefore surfaces across months instead of arriving. The material is a prompt, not the outcome.
Radiesse is calcium hydroxylapatite — CaHA — microspheres suspended in a gel carrier, used primarily for restoring facial volume and improving the appearance of wrinkles and folds. It can also be used in diluted or hyperdiluted formulations for certain skin-quality approaches, depending on the plan.
Now the divergence. Radiesse's gel carrier does the ordinary work of a filler: material is placed, contour changes, and the change is there when you stand up. The collagen effect follows behind it over the following months. Sculptra has no equivalent first act. Whatever appears, appears because your tissue built it, which is why nothing is visible in the early weeks.
So the shared mechanism is real but it is not the useful part of the comparison. What separates them is whether anything happens today.
What each is used for, and where
The treatment areas sort the two products almost as cleanly as the tempo does.
Sculptra at this clinic is used for the mid-face, the temples and other volume-deficient areas — structural regions, where loss shows up as a change in the shape of a face rather than in the quality of its surface. Candidates are adults with age-related facial volume loss, reduced firmness, fine lines or wrinkles, who prefer gradual improvement and are medically suitable for injectable treatment.
Radiesse addresses volume lost with age, wrinkles and folds in the moderate-to-severe range, and particular areas that need structural support. Whether it suits you turns on anatomy, skin condition, medical history and what you are trying to achieve.
Note the overlap and the edge. Both address lost volume; only one is documented here for the temples and mid-face specifically, and only one comes with a published route into skin-quality work through dilution. If your concern is a hollow temple, the list narrows on its own. If it is a fold that has deepened, both are candidates and something else has to break the tie.
The two questions that break the tie
When the anatomy does not settle it, these do — in this order.
Can you wait, and will you be here to look?
Radiesse gives an early structural effect, with the collagen half fullest at about three months and overall duration commonly discussed as around 12 to 18 months, on one session per cycle reviewed at the three-month mark. Sculptra gives you nothing for the first month or so; early change comes from about six to eight weeks, the fullest effect arrives at about six months, and it is a series of sessions spaced several weeks apart rather than one visit.
For someone traveling to Jeju, that difference is not academic. One of these is a single appointment whose result you can partly see before you leave. The other is a commitment to come back, or to have a plan for what a partial series produces if you cannot. Ask that question specifically — not "how many sessions", but "what happens to the result if I complete two of three".
On longevity the ranking is not close: the poly-L-lactic acid option is the longest-lasting injectable on this clinic's menu, comfortably beyond the CaHA product's window, and the full-length guide to that product covers its horizon in detail. But longevity is a poor first criterion for a visiting patient, because a longer arc you cannot complete is worth less than a shorter one you can.
How much of the result do you want to be yours?
This sounds like a philosophical question and it is actually a practical one. With a product whose visible effect is your own collagen, there is no day on which it can look overdone, because nothing was added to look overdone with. With a product that places material, there is — and equally, there is a day on which you can see whether the placement was right.
Some people strongly prefer the first. Others would rather see the result and know. Neither preference is wrong, and a clinician who asks which one you hold is doing the consultation properly. The American Academy of Dermatology's overview of how long fillers last and its filler FAQs are both useful for calibrating what "seeing the result" reasonably means before you are in the chair.
Risk profiles that are not interchangeable
This is the part of the comparison most often flattened into "both are injectables", and flattening it does the reader a disservice.
For Sculptra the usual after-effects are what any injection produces — discomfort or pain, tenderness, bruising, swelling and redness. Beyond those, lumps or nodules that persist, and other complications, are possible. That is why technique and assessment carry real weight with a product placed at depth and then left to work for months.
For Radiesse, the ordinary temporary effects at an injection site are firmness, itching, bruising, tenderness, redness and swelling. The uncommon but serious list runs further: skin injury, vascular occlusion, nodules, infection, and — rarely — complications involving vision.
The second list contains something the first does not, and it is worth understanding rather than skimming. Vascular occlusion is uncommon, it belongs to products that occupy space in tissue, and it is the reason "who is injecting, and what is their training" is a fair question to put directly to any clinic offering a structural product. The US Food and Drug Administration maintains a list of approved soft tissue fillers and consumer guidance on preparing for filler treatment is published by the Academy of Dermatology; both are worth reading before a first structural injectable rather than after one.
Where this comparison stops being useful
It is worth naming the cases in which neither of these is the answer, because a head-to-head invites you to pick a winner from a field of two.
If what bothers you is the quality of the surface — texture, pores, dullness, fine crepiness across an area rather than a hollow in one place — you are describing a concern that sits outside what either product is primarily documented for here. There is a route into skin-quality work through the diluted CaHA preparation, and it is a real one, but it is not the main use and it should be proposed deliberately rather than reached for because you happened to ask about this pair.
If what has changed is the amount of skin rather than the amount of volume beneath it, an injectable is the wrong category altogether. Neither of these removes skin and neither replaces what surgery does when surgery is what the anatomy requires. A clinic that says so plainly, at the point where you were expecting a recommendation, is worth more than one that finds you a product.
And if you are unsure which of those three descriptions fits you, say exactly that at consultation. "I do not know whether this is volume or texture" is a more useful sentence than a confident guess, and it is the kind of thing an assessment exists to settle.
Keeping a record you will need later
Whichever you choose, you will be judging the outcome from another country on a timescale of months, and that is a situation people handle badly without help.
Write down the product, the amount, the areas treated, the date and — for the CaHA option — whether a standard or diluted preparation was used. The clinic makes translated documents available, which puts this well inside what you can reasonably ask for. MedlinePlus, the US National Library of Medicine's patient service, explains why keeping a personal health record is worth the effort; for a treatment still developing three months after you get home, it is what turns a vague memory into something a clinician can act on.
Take photographs on the day, before anything is done, and repeat them in the same light and position at the review point. On a slow product this is not optional — a change that accrues across months is genuinely invisible to the person it happens to, and an impression is no substitute for a comparison.
Choosing without a specification sheet
If you take one thing from this comparison, make it the order of the questions.
Start with what your face has lost and where, because that eliminates more options than anything else. Then ask what your calendar can actually support, because a plan you abandon halfway is worse than the plan you did not start. Only then think about duration, and hold it loosely.
What you should not do is choose on the mechanism. Both of these build collagen; that shared fact tells you nothing about which suits you, and it is the line most often used to sell whichever one is being sold.
Put your questions in writing before you commit to anything — what you would recommend for my concern, why that one, how many sessions, what you would want to see at review, and what happens if I cannot return. They go to the contact page, and the about page describes the practice that will answer them.
The Bottom Line
- Both products prompt your own collagen, but only the calcium hydroxylapatite option also places material that changes contour on the day; the poly-L-lactic acid option shows nothing early.
- Treatment areas sort them further: the mid-face, temples and other volume-deficient regions for one; volume loss, moderate-to-severe folds and selected structural support for the other.
- Radiesse peaks at about three months and is commonly discussed at around 12 to 18 months, on one session per cycle; Sculptra starts at six to eight weeks, peaks at about six months, and runs as a series of sessions.
- The risk profiles differ in kind rather than degree: occupying space in tissue carries vascular and, rarely, vision-related complications that a slow collagen prompt does not.
- Choose on anatomy first and on what your travel schedule can complete second; duration is the weakest reason to pick either.
Frequently Asked Questions
What is the main difference between them?
Tempo. Radiesse produces an early structural effect and then a collagen effect over months; Sculptra produces nothing early and builds entirely through your own collagen over a matter of months.
Which one works for the temples?
Sculptra is the product this clinic documents for the mid-face, temples and other volume-deficient areas. Bring the specific area to consultation, since suitability depends on your own anatomy.
How many appointments does each take?
Radiesse is generally one session per cycle, reviewed at three months. Sculptra is a series of sessions spaced several weeks apart, which is a materially larger commitment if you are visiting.
How long does a session take?
Sculptra runs about 30 to 45 minutes of chair time. Radiesse typically takes 30 to 60 minutes depending on the area and the amount required.
Which one lasts longer?
The poly-L-lactic acid product does, by a clear margin — it is the longest-lasting injectable on this clinic's menu. Radiesse is commonly discussed as around 12 to 18 months.
Are the risks the same?
No. Both share the usual injection-site effects, but the calcium hydroxylapatite product carries a category of complication tied to occupying space in tissue, including vascular occlusion and, rarely, vision-related complications.
Can they be used together?
Combination and sequencing are clinical decisions that depend on what your face needs and in what order. Ask for the reasoning rather than assembling a plan from a menu.
What should I bring home with me?
A written record of the product, the amount, the areas treated, the date, and whether a diluted preparation was used — plus a baseline set of photographs taken on the day of treatment.
This article is for general informational purposes only and does not constitute individualized medical advice. It is not a self-diagnosis tool, and it cannot replace an in-person assessment by a licensed dermatologist who has examined your skin.
More Articles
Continue reading our clinical guides.
Ultherapy PRIME Lifting in Korea: What to Expect
Ultherapy PRIME lifting at Liyan Clinic in Jeju: how micro-focused ultrasound works, who it suits, the honest results timeline, and how US patients plan it.
Learn More
Potenza RF Microneedling: Texture, Pores, and Scars
Potenza RF microneedling at Liyan Clinic in Jeju: how needles plus radiofrequency treat texture and acne scars, how long a course runs, and what to ask.
Learn More
Thermage FLX RF Skin Tightening: A Patient's Guide
Thermage FLX at Liyan Clinic in Jeju: how monopolar radiofrequency tightening works, what the shot count means, the results timeline, and who it suits.
Learn More